AtriCure (ATRC) Equity Average (2011 - 2026)

AtriCure (ATRC) has 16 years of Equity Average data on file, last reported at $491.8 million in Q1 2026.

• Quarterly Equity Average rose 7.43% year-over-year to $491.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $491.8 million (up 7.43% YoY) and the FY2025 annual result came in at $476.5 million, up 2.78% from the prior year.
• Equity Average grew to $491.8 million in Q1 2026 per ATRC's latest filing, from $484.2 million in the prior quarter.
• Across five years, Equity Average topped out at $491.8 million in Q1 2026 and bottomed at $453.5 million in Q3 2022.
• The 5-year median for Equity Average is $461.2 million (2024), against an average of $464.3 million.
• Peak annual rise in Equity Average reached 18.45% in 2022, while the deepest fall reached 6.7% in 2022.
• Tracing ATRC's Equity Average over 5 years: stood at $453.5 million in 2022, then advanced by 2.42% to $464.5 million in 2023, then declined by 0.32% to $463.0 million in 2024, then grew by 4.58% to $484.2 million in 2025, then climbed by 1.57% to $491.8 million in 2026.
• Per Business Quant, the three latest ATRC Equity Average figures stand at $491.8 million (Q1 2026), $484.2 million (Q4 2025), and $470.5 million (Q3 2025).

Peer Comparison